Results 241 to 250 of about 27,161 (265)

AI Driven Pharmacovigilance Case Study

Adverse drug reactions (ADRs) due to drug toxicity pose serious risks, often leading to severe health complications or fatalities. Current pharmacovigilance systems rely on clinical trials and post-market surveillance but lack real-time patient insights.
Ruchi Jakhmola Mani, Barsha Rani Bora, Nureen Amin, Manan Garg, Kusala Vanam, Snigdha Debashis Bhattacharjee   +5 more
openaire   +1 more source

Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources

Drug Safety, 2022
Mengchun Gong, Tianyong Hao, Likeng Liang   +2 more
exaly  

Situation analysis of the pharmacovigilance system in Nepal using the indicator-based pharmacovigilance assessment tool (IPAT)

Journal of Pharmaceutical Health Services Research, 2021
P Ravi Shankar, Subish Palaian, Nisha Jha   +2 more
exaly  

High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study

Journal of Clinical Epidemiology, 2021
Antoine Pariente, Charles Khouri, Marion Lepelley   +2 more
exaly  

Development of Pharmacovigilance System in India and Paradigm of Pharmacovigilance Research: An Overview

Current Drug Safety, 2023
Yogesh Vaishnav, Shekhar Verma, Preeti Singh   +2 more
exaly  

Pharmacovigilance Activities in 55 Low- and Middle-Income Countries

Drug Safety, 2012
Sten Olsson, Andy Stergachis, Stergachis Andy   +2 more
exaly  

The history of pharmacovigilance

Therapie, 2016
Michael Rochoy, Sophie Gautier
exaly  

The role of data mining in pharmacovigilance

Expert Opinion on Drug Safety, 2005
Eugene Van Puijenbroek, Manfred Hauben
exaly  

Uses of pharmacovigilance databases: An overview

Therapie, 2020
Benedicte Lebrun-Vignes, Kevin Bihan, Joe-Elie Salem   +2 more
exaly  

French pharmacovigilance: Missions, organization and perspectives

Therapie, 2016
Thierry Vial
exaly